Malignant Neoplasm
Conditions
Brief summary
This pilot clinical trial studies evidence-based tobacco cessation strategies in patients with cancer. Stop-smoking plans suggested by doctors may help patients with cancer quit smoking.
Detailed description
PRIMARY OBJECTIVES: I. To assess oncology providers' self-reported need for training on evidence-based tobacco cessation strategies and assess their level of interest in future training on evidence-based tobacco cessation strategies. II. To test the feasibility of the implementation of evidence-based tobacco cessation strategies in community oncology clinics. III. To test the feasibility of surveying community oncology patients after a clinic visit to assess provider behavior regarding screening and brief intervention for tobacco use. OUTLINE: Patients complete a survey over approximately 10-15 minutes related to their provider's cessation advice and assistance with quitting. After completion of study, patients are followed up at 1 month.
Interventions
Receive evidence-based tobacco cessation strategies
Ancillary studies
Ancillary studies
Sponsors
Study design
Eligibility
Inclusion criteria
* All patients with cancer who saw a provider will be eligible
Exclusion criteria
* Having a nurse or lab visit only
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of providers from the Piedmont Oncology Association (POA) reporting a need for training on evidence-based tobacco cessation strategies | Up to 1 month | Will be estimated and 95% confidence intervals (CI) constructed. |
| Percentage reporting feeling very confident in their ability to counsel smokers | Up to 1 month | Will be estimated and 95% CI constructed. |
| Percentage reporting they would be willing to participate in training on evidence-based tobacco cessation strategies | Up to 1 month | Will be estimated and 95% CI constructed. |
| Proportion of oncology patients willing to complete a survey in an oncology clinic | Up to 1 month | Will be estimated and 95% CI constructed. |
| Proportion of patients who report that their provider asked about tobacco use during their visit | Up to 1 month | These prevalences will be estimated at pre- and post-intervention, and 95% CIs calculated adjusting for the expected within-clinic correlation of patient outcomes. These outcomes will be analyzed further using a subject-specific modeling approach to account for the correlation that occurs due to patients being clustered within clinics. |
| Proportion of current smokers who report that their provider advised them to quit during their visit and provided tobacco-cessation strategies | Up to 1 month | These prevalences will be estimated at pre- and post-intervention, and 95% CIs calculated adjusting for the expected within-clinic correlation of patient outcomes. These outcomes will be analyzed further using a subject-specific modeling approach to account for the correlation that occurs due to patients being clustered within clinics. |
Countries
United States